Michaela Matthey
Targeted inhibition of Gq signaling induces airway relaxation in mouse models of asthma
Matthey, Michaela; Roberts, Richard; Seidinger, Alexander; Simon, Annika; Schr�der, Ralf; Kuschak, Markus; Annala, Suvi; K�nig, Gabriele M.; M�ller, Christa E.; Hall, Ian P.; Kostenis, Evi; Wenzel, Daniela
Authors
RICHARD ROBERTS richard.roberts@nottingham.ac.uk
Associate Professor
Alexander Seidinger
Annika Simon
Ralf Schr�der
Markus Kuschak
Suvi Annala
Gabriele M. K�nig
Christa E. M�ller
IAN HALL IAN.HALL@NOTTINGHAM.AC.UK
Professor of Molecular Medicine
Evi Kostenis
Daniela Wenzel
Abstract
Obstructive lung diseases are common causes of disability and death worldwide. A hallmark feature is aberrant activation of Gq protein–dependent signaling cascades. Currently, drugs targeting single G protein (heterotrimeric guanine nucleotide–binding protein)–coupled receptors (GPCRs) are used to reduce airway tone. However, therapeutic efficacy is often limited, because various GPCRs contribute to bronchoconstriction, and chronic exposure to receptor-activating medications results in desensitization. We therefore hypothesized that pharmacological Gq inhibition could serve as a central mechanism to achieve efficient therapeutic bronchorelaxation. We found that the compound FR900359 (FR), a membrane-permeable inhibitor of Gq, was effective in silencing Gq signaling in murine and human airway smooth muscle cells. Moreover, FR both prevented bronchoconstrictor responses and triggered sustained airway relaxation in mouse, pig, and human airway tissue ex vivo. Inhalation of FR in healthy wild-type mice resulted in high local concentrations of the compound in the lungs and prevented airway constriction without acute effects on blood pressure and heart rate. FR administration also protected against airway hyperreactivity in murine models of allergen sensitization using ovalbumin and house dust mite as allergens. Our findings establish FR as a selective Gq inhibitor when applied locally to the airways of mice in vivo and suggest that pharmacological blockade of Gq proteins may be a useful therapeutic strategy to achieve bronchorelaxation in asthmatic lung disease.
Citation
Matthey, M., Roberts, R., Seidinger, A., Simon, A., Schröder, R., Kuschak, M., …Wenzel, D. (in press). Targeted inhibition of Gq signaling induces airway relaxation in mouse models of asthma. Science Translational Medicine, 9(407), https://doi.org/10.1126/scitranslmed.aag2288
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 10, 2017 |
Online Publication Date | Sep 13, 2017 |
Deposit Date | Sep 21, 2017 |
Publicly Available Date | Sep 21, 2017 |
Journal | Science Translational Medicine |
Print ISSN | 1946-6234 |
Electronic ISSN | 1946-6242 |
Publisher | American Association for the Advancement of Science |
Peer Reviewed | Peer Reviewed |
Volume | 9 |
Issue | 407 |
DOI | https://doi.org/10.1126/scitranslmed.aag2288 |
Public URL | https://nottingham-repository.worktribe.com/output/882345 |
Publisher URL | http://stm.sciencemag.org/content/9/407/eaag2288 |
Contract Date | Sep 21, 2017 |
Files
Matthey1709131.pdf
(1.7 Mb)
PDF
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search